TY - JOUR
T1 - Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents
T2 - Multicentre, randomised controlled trial
AU - Staab, Doris
AU - Diepgen, Thomas L.
AU - Fartasch, Manigé
AU - Kupfer, Jörg
AU - Lob-Corzilius, Thomas
AU - Ring, Johannes
AU - Scheewe, Sibylle
AU - Scheidt, Reginald
AU - Schmid-Ott, Gerhard
AU - Schnopp, Christina
AU - Szczepanski, Rüdiger
AU - Werfel, Thomas
AU - Wittenmeier, Marita
AU - Wahn, Ulrich
AU - Gieler, Uwe
PY - 2006/4/22
Y1 - 2006/4/22
N2 - Objective: To determine the effects of age related, structured educational programmes on the management of moderate to severe atopic dermatitis in childhood and adolescence. Design: Multicentre, randomised controlled trial. Setting: Seven hospitals in Germany. Participants: Parents of children with atopic dermatitis aged 3 months to 7 years (n=274) and 8-12 years (n=102), adolescents with atopic dermatitis aged 13-18 years (n=70), and controls (n=244, n=83, and n=50, respectively). Interventions: Group sessions of standardised intervention programmes for atopic dermatitis once weekly for six weeks or no education (control group). Main outcome measures: Severity of eczema (scoring of atopic dermatitis scale), subjective severity (standardised questionnaires), and quality of life for parents of affected children aged less than 13 years, over 12 months. Results: Significant improvements in severity of eczema and subjective severity were seen in all intervention groups compared with control groups (total score for severity: age 3 months to 7 years - 17.5, 95% confidence intervals - 19.6 to - 15.3 v - 12.2, - 14.3 to - 10.1; age 8-12 years -16.0, - 20.0 to - 12.0 v - 7.8, - 11.4; - 4.3; and age 13-18 years - 19.7, - 23.7 to - 15.7 v - 5.2, - 10.5 to 0.1). Parents of affected children aged less than 7 years experienced significantly better improvement in all five quality of life subscales, whereas parents of affected children aged 8-12 years experienced significantly better improvement in three of five quality of life subscales. Conclusion: Age related educational programmes for the control of atopic dermatitis in children and adolescents are effective in the long term management of the disease.
AB - Objective: To determine the effects of age related, structured educational programmes on the management of moderate to severe atopic dermatitis in childhood and adolescence. Design: Multicentre, randomised controlled trial. Setting: Seven hospitals in Germany. Participants: Parents of children with atopic dermatitis aged 3 months to 7 years (n=274) and 8-12 years (n=102), adolescents with atopic dermatitis aged 13-18 years (n=70), and controls (n=244, n=83, and n=50, respectively). Interventions: Group sessions of standardised intervention programmes for atopic dermatitis once weekly for six weeks or no education (control group). Main outcome measures: Severity of eczema (scoring of atopic dermatitis scale), subjective severity (standardised questionnaires), and quality of life for parents of affected children aged less than 13 years, over 12 months. Results: Significant improvements in severity of eczema and subjective severity were seen in all intervention groups compared with control groups (total score for severity: age 3 months to 7 years - 17.5, 95% confidence intervals - 19.6 to - 15.3 v - 12.2, - 14.3 to - 10.1; age 8-12 years -16.0, - 20.0 to - 12.0 v - 7.8, - 11.4; - 4.3; and age 13-18 years - 19.7, - 23.7 to - 15.7 v - 5.2, - 10.5 to 0.1). Parents of affected children aged less than 7 years experienced significantly better improvement in all five quality of life subscales, whereas parents of affected children aged 8-12 years experienced significantly better improvement in three of five quality of life subscales. Conclusion: Age related educational programmes for the control of atopic dermatitis in children and adolescents are effective in the long term management of the disease.
UR - http://www.scopus.com/inward/record.url?scp=33646033779&partnerID=8YFLogxK
U2 - 10.1136/bmj.332.7547.933
DO - 10.1136/bmj.332.7547.933
M3 - Article
C2 - 16627509
AN - SCOPUS:33646033779
SN - 0959-8146
VL - 332
SP - 933
EP - 936
JO - BMJ
JF - BMJ
IS - 7547
ER -